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Collaboration across professions in patient care plays a significant role in the success of the Triple Aim, and healthcare professionals must be properly trained to provide this collaborative care. 1, 2 While the Triple Aim addresses the outcomes of health system services, a revised version, the Quadruple Aim, also addresses the health of individuals who provide patient care. 3 Studies show that burnout is high among physicians, with family medicine physicians experiencing one of the highest burnout rates in medical practice. 4, 5 Bodenheimer and Sinsky suggested using a team approach to the provision of patient care in order to better balance the physician's workload. 3 Pharmacists, a relative newcomer to the outpatient clinical team, can positively impact patient care by performing some of the tasks historically done by physicians, which can alleviate physician burnout. 6 When
Corresponding author: Keri Hager, PharmD, BCACP Associate Professor, Director, UMD MTM Clinic Phone: 218-726-6013; Email: khager@umn.edu pharmacists are a member of the primary care team, they provide benefits, such as answering drug information questions, communicating with the team about medication issues, increasing prescribing safety, and educating patients and providers. [7] [8] [9] [10] [11] The literature also provides strong support for pharmacist-physician collaboration to improve health outcomes, as shown through significantly improved patient A1c, blood pressure, and asthma control after pharmacist interventions. [12] [13] [14] [15] [16] [17] [18] When pharmacists are a part of the healthcare team, physicians see value in their services. 7, 8, 11 While it is well understood that a pharmacist-physician collaboration model can improve health outcomes, the methods for fostering these collaborations is less clear. Brock and Doucette tested a model of collaborative working relationships between physicians and pharmacists, which shows that this collaboration goes through five stages. 19 These stages start with professional awareness (stage 0), move through professional recognition (stage 1), exploration and trial (stage 2), and professional relationship expansion (stage 3), and end with a commitment to a collaborative working relationship (stage 4). However, the model was tested with practitioners who had been in practice an average of at least 14 years, and with pharmacists
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2 practicing in community pharmacies rather than co-located with physicians.
Interprofessional learning begins early in a health profession student's education and accelerates into graduate training as residents and finally as healthcare professionals. 20 In Family Medicine, the Accreditation Council for Graduate Medical Education (ACGME) emphasizes the importance of team-based care. Residents are assessed on their understanding of roles and responsibilities of healthcare team members and their ability to engage in appropriate team-based care. 21 Examination of this graduate level of training may provide a better understanding of how to improve pharmacist/physician collaboration. Understanding underlying knowledge and perceptions of pharmacist/physician collaboration may guide interventions to intentionally enhance collaboration. In the health sciences education literature, this is an area with limited published data. 9 Additionally, there is little research about knowledge and perceptions of collaboration among pharmacists involved in Family Medicine residency programs.
The objective of this study was to explore knowledge and perceptions of pharmacist-physician collaboration among family medicine residents (FMR), family medicine faculty (FMF), and pharmacists (P), including pharmacist faculty and pharmacy residents. This information will provide insight for improvement of FMR education to better prepare learners for patientcentered, team-based practice.
METHODS

Research Design
An exploratory, descriptive, qualitative study design was used to articulate perceptions of professional roles and team-based care in an interprofessional family medicine community-based clinical practice.
Setting
The study took place from January 8 to May 11, 2015 at the Duluth Family Medicine Residency Program (DFMRP), an affiliate of the University of Minnesota School of Medicine Department of Family Medicine and Community Health located in Duluth, Minnesota. DFMRP's goal is to prepare family medicine physicians for collaborative rural primary care practice. 22 This primary care practice is comprised of family medicine faculty (including behavioral health and social work faculty), family medicine residents (first year, G1; second year, G2; third year, G3), ambulatory clinical pharmacists, and rotating pharmacy residents.
The clinical pharmacists had been providing comprehensive medication management services in the clinic for 2.5 years at the time the study took place. 23 The care team also includes nurses, medical assistants, and other clinic staff. The family medicine residents have progressively more time in the clinic, ranging from two to four half-days per week, and see an average of six patients per half-day. Team huddles occur prior to each shift, and all health professionals are co-located in a team area with each profession available for care conferences.
Participants
Given the study objective to explore knowledge and perceptions of pharmacist-physician collaboration, the investigators used purposive sampling and selected the following providers affiliated with DFMRP: FMR (G1, n=8; G2, n=10; G3, n=9), FMF (physicians, n=6; behavioral health practitioners, n=2), ambulatory clinical pharmacists from the clinic (n=2), and pharmacy residents from the clinic (n=2) and hospital (n=2) where the FMRs interacted. FMR trainees and their faculty, as well as pharmacists, were included to get diverse perspectives of pharmacist-physician collaboration in the clinic. The ambulatory clinical pharmacists and pharmacy residents were combined into one group because of their small number and because they all provide comprehensive medication management services. In addition, the authors reasoned that medical residents with more exposure to clinical pharmacy services (i.e., residents further along in their training) may have differing opinions about pharmacist-physician collaboration than earlier learners. Therefore, the FMR focus groups were divided into G1, G2, and G3 resident cohorts.
Interview Guide An interview guide comprised of seven questions and corresponding probes was developed by one of the authors (KH) to facilitate discussions about knowledge and perceptions of professional roles and team collaboration. Prior to using the interview guide, the questions and probes were reviewed by members of an interprofessional education advisory board that was comprised of the residency program director and the two ambulatory clinical pharmacists. This board was chosen to provide critical feedback because of their clinical expertise, interest in understanding FMR perceptions of collaboration with pharmacists, and support of enhanced collaboration between physicians and pharmacists. Several of the interview questions were tailored specifically for pharmacists. For example, the question "What is the pharmacist's role/responsibility in teambased care?" used with the FMRs and FMFs was reworded to "What are your roles/responsibilities in team-based care?" when speaking to the pharmacists. The interview guide is provided in Appendix A.
Data Collection Procedure
Five, 60-minute focus groups were conducted for this study: (1) FMR -G1, (2) FMR -G2, (3) FMR -G3, (4) FMF, and (5) ambulatory clinical pharmacists and pharmacy residents. The FMR and FMF focus groups were conducted in the Family Medicine Clinic during a regularly scheduled one-hour meeting, whereas the pharmacist group was conducted at another primary care clinic site within the health system. Participants were invited to participate either by the residency program director (physician groups) or the ambulatory clinical pharmacist (pharmacist group) in person or by email. Focus groups were facilitated by one author (KH), who was not part of the clinical site, but was known by some of the participants through her work with their interprofessional education advisory group. Focus groups were audio recorded and transcribed verbatim. A pharmacy student took notes during each interview to supplement the transcript data. This research was approved by the University of Minnesota Institutional Review Board and was exempt from full review.
Data Analysis Content analysis of transcripts was conducted by the four investigators using a classic analysis strategy. 24 Coding of the transcripts was completed manually in three steps. In the first step, two authors (KH, CM) independently coded the transcripts and came to consensus on codes and categories through discussion. Once consensus was achieved, a third author (DU) independently coded the transcripts. The three coders then arrived at consensus on codes and categories through discussion. To strengthen the rigor of the data analysis, the investigators invited a physician (BS) to code all of the data independently. Following this independent analysis, all four coders came to consensus on the main themes and subthemes that emerged from the data. The coders started with open coding of the text and then proceeded to develop categories using axial coding. 25 For example, the open codes of "pharmacist role -medication reviews (clinic)," "pharmacist role -medication adherence (clinic)," and "pharmacist role -prevention (clinic)," were later merged into an overarching category called "pharmacist roleclinic." A multistage data analysis procedure was implemented to ensure that no new themes emerged from the data and theoretical saturation was achieved for each of the identified themes and subthemes. 26 The study participants did not review any of the transcripts; however, a summary of findings and recommendations was presented to the residency program director and the interprofessional education advisory group members for their review and feedback. This step was added to assess the credibility and overall trustworthiness of the study findings. 27 RESULTS Twenty-one out of 27 family medicine residents (7 G1, 8 G2, 6 G3), 8 family medicine faculty, and 6 pharmacists participated in the focus groups. The analysis of the focus groups yielded three primary themes and corresponding subthemes ( Table 1) . Details of the themes and supporting quotes are provided below. Attribution for each of the quotes is given as FMF (family medicine faculty), FMR (family medicine resident) and P (pharmacist). The FMRs are listed by year of residency G1-G3. The individual participants are designated by M (male) or F (female) and a number. 
FMR Education Provided by Pharmacists
Didactic education provided by pharmacists was considered high quality, relevant, and well-delivered. Educational efforts by FMF and clinical pharmacists/residents were targeted to the FMR learners. FMR and FMF reported pharmacists were a helpful resource who knew about both preventive health issues (e.g., immunizations) and specific medication-related issues (e.g., dosing, entering medication orders in the electronic health record).
"Their depth and breadth of knowledge, their willingness to dig deep into a topic, their willingness to teach. In our residency program, we have a chronic disease management curriculum, and the pharmacists have been integral in that process." FMF F1 "The pharm lectures are probably the highest yield lectures that we have." G2 FMR M2
However, there was not a reciprocal benefit to the pharmacists.
"I didn't really feel like we get a whole lot of education from them." P F4
Pharmacists providing education to the FMRs about the roles and responsibilities of the pharmacist on the team was seen as important by the FMRs and FMF. Most FMRs and FMF favored the idea that the FMRs need to understand what and how pharmacists do their work because if certain clinical pharmacy services are not available at future practice sites, FMRs should have the capability to quickly learn these skills, consult colleagues when necessary, and even advocate for practice change to include clinical pharmacy services.
"Sometimes the residents are over reliant on the pharmacists to, for example, come up with an antibiotic dosing regimen." FMF F4
Theme 3: Keys to successful pharmacist-physician collaboration Successful collaborations between pharmacists and physicians were described in five domains: a) develop the relationship, b) optimize communication, c) create beneficial clinical workflow, d) clarify roles and responsibilities, and e) increase opportunities for meaningful interactions.
Develop the Relationship
The key components to developing an effective collaborative relationship that emerged from all groups included trust, respect, previous experiences, and access/availability .
"I think mutual respect, too. If there's ever any pointing fingers between one or the other about something wrong that's starting off [on the wrong foot]." G3 FMR F4
Optimize Communication
FMRs would like access to a pharmacist they trust 24 hours a day and seven days a week, especially where they can communicate face-to-face in real time. They were not always certain how to access clinical pharmacy services (ambulatory or inpatient), when a pharmacist was not on site in the clinic. There was variability in the means and frequency with which FMRs access clinical pharmacy services (phone, electronic health record, email), although face-to-face seemed to be the preferred mode. If a pharmacist was not available to speak face-to-face, FMRs would contact pharmacists with whom they were familiar. The FMF also spoke to the value of having everybody in the same room at the same time and how that facilitated the ability to effectively communicate. They expressed a desire for this to be true in all settings where they interact with pharmacists.
"The best thing we've done collaboratively is to actually put our interdisciplinary team in the same space." FMF F3 "I think definitely working side by side in the hospital or clinic makes a big difference." G2 FMR M2
Create Beneficial Clinical Workflow FMRs, FMF, and pharmacists thought the best model of practice was for the pharmacist to see the patient in the clinic before the FMR. The pharmacists captured a comprehensive medication list and provided recommendations to the FMR immediately before the FMR saw the patient. FMRs appreciated that pharmacists maintained the FMR-patient relationship by providing only education to the patients and making their recommendations about medication changes directly to the FMR rather than to the patient. This communication protocol helped to prevent unreasonable patient expectations.
"The thing that's nice about it is that they'll discuss it with the patient, but the patient does not have the expectation that when I walk in the room that's the changes I'm going to make" G2 FMR F2
Clarify Roles/Responsibilities
FMRs and FMF recognized that roles of pharmacy residents and pharmacists overlap. In the hospital and clinic, they viewed pharmacy residents as transient pharmacists, but used their services in the same manner as their clinical pharmacist preceptors.
"They're used interchangeably because the pharmacy residents are fabulous." FMF F1
Additionally, they recognized that some pharmacist and FMR patient care roles overlap (e.g., preventative care, medication review, and patient education).
"[I am] impressed at how much clinical medicine and how many clinical guidelines the pharmacists know -even better than a lot of physicians." G2 FMR M3
No focus group participants clearly articulated a model for "team accountability" for patient care, but they recognized that if someone accepts the responsibility for a task, then they were accountable for the outcome.
"If you asked that to be done, they took the baton. They're dosing. They're responsible." FMF F1
Increase Opportunities for Meaningful Interactions
FMRs felt getting to know their pharmacy colleagues would facilitate understanding roles and responsibilities and would promote collaboration. FMRs, FMF, and pharmacists described multiple ways to develop a collaborative relationship, including having inpatient and outpatient pharmacy residents, FMRs, and community pharmacists participate in resident orientation or inviting a community pharmacist to a noon conference and to see some patients together in clinic. FMF also suggested that pharmacists be faculty in the residency program and participate in faculty meetings.
"A noon conference with a panel of small town pharmacists talking about how they work with physicians in those small communities." FMF F2 "I think it would be really beneficial to have a group meeting in the very beginning of the residency year." P F2 DISCUSSION A summary of findings and recommendations was presented to the residency program director and the interprofessional education advisory group members for their review and feedback. As a result, several changes were developed and implemented to facilitate collaboration, including enhanced interprofessional orientation activities, creation of collaborative practice agreements, and opportunities for FMRs to take an elective rotation with a community pharmacist (Appendix B).
This study found that the pharmacist and physician groups, including residents, recognize the benefits of a collaborative care model, including time efficiency, patient care safety, and education of the medical residents. It was surprising that the perceived benefits to collaboration in this study were consistent across all levels of medical residents. The expectation would be that greater exposure over time would have increased the benefits of collaboration. Perhaps the level of collaboration is fixed, which limits the opportunities for enhanced benefits with increased exposure.
There are, however, opportunities to improve the level of collaboration between pharmacists and physicians. Based on Brock and Doucette's five stages of collaborative working relationships, the pharmacist-physician groups are working at a mid-stage. 19 The two professions have moved beyond an awareness of each other (stage 0), and have built a foundation of trust (stage 1), within the clinic setting, and are now beginning to assess the pharmacist's clinical abilities within that clinical setting (stage 2). Except in the case of questions specifically about medication management or for referral for disease-specific interventions, such as anticoagulation management, there is not yet interdependence on one another (stage 3). The pharmacist is still the primary initiator of clinical partnerships. 19 To fully move to the final stage, Commitment to Collaborative Working Relationship (stage 4), the physicians would have to see that the benefits of collaboration outweigh any risks and that there is consistent input and physical pharmacist presence. 19 This study identified five keys to a successful collaboration between pharmacists and physicians, which could assist in moving resident physicians and pharmacists to higher stages of collaboration. These include developing relationships, optimizing communication, creating beneficial clinical workflow, clarifying roles and responsibilities, and increasing opportunities for meaningful interactions. There are many strategies for advancing these keys to successful collaboration. The study participants mentioned such things as co-locating the two professions, inviting more people to noon conferences, and improving the ability to access each other's services at all times of the day. Pharmacists can also explicitly educate physicians about what occurs in a medication management visit, the types of patients that could benefit, and provide clear instructions about how to refer patients for pharmacy services. 9 Another intervention is to increase the frequency of face-to-face interactions, which will help to develop a relationship that increases trust between the professions. 28, 29 It is also important to emphasize how the work of the two professions can be complementary and reinforce the benefits of each other's expertise such that there is a win-win relationship.
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A limitation of this study is that it occurred in only one site; research in additional sites may yield further insights. Additionally, there were not enough family medicine faculty from the different professions to analyze their data separately. The knowledge and perceptions of the pharmacy residents and faculty may vary among the faculty professions, and further research is warranted. Future research is needed to measure the impact of increased pharmacist-FMR collaboration on patient care outcomes, and also to explore collaboration with integrated behavioral health faculty and learners. CONCLUSION Enhanced collaboration will evolve and strengthen in a clinical environment where each team member knows the roles of each profession and uses those roles to optimize the way the professionals communicate, interact, and provide patient care. This study in a practice with relatively new clinical pharmacy services shows that by co-locating physicians and pharmacists in the same setting, and providing a basic structure for collaboration, a collaborative working relationship can be facilitated. Practices looking to have more effective collaborative working relationships should strive to increase the frequency of interactions of the professionals, help the physicians understand the abilities of pharmacists, and help the pharmacists articulate to the physicians the value of what they provide to patients. The five keys to successful collaboration identified in this study are building blocks to advance a robust collaborative working relationship that positively benefits patient care and achieves the Quadruple Aim. 
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